Table 2.
Correlation table of main study variables.
| Variable 1 | Variable 2 | Correlation | FDR-corrected p-value |
|---|---|---|---|
| baseline life interference | age | 0.03 | 0.90 |
| baseline severity (SPQ) | age | -0.05 | 0.83 |
| baseline severity (MFS) | age | -0.26 | 0.13 |
| baseline pos affect | age | 0.29 | 0.08 |
| baseline neg affect | age | -0.02 | 0.93 |
| PROMIS anxiety | age | -0.03 | 0.90 |
| anxiety in exposure 1 | age | 0.13 | 0.71 |
| anxiety in exposure 2 | age | 0.12 | 0.73 |
| life interference after VRET | age | 0.30 | 0.21 |
| severity after VRET (SPQ) | age | 0.28 | 0.23 |
| severity after VRET (MFS) | age | -0.04 | 0.90 |
| baseline severity (SPQ) | baseline life interference | 0.80 | <.001 |
| baseline severity (MFS) | baseline life interference | 0.73 | <.001 |
| baseline pos affect | baseline life interference | 0.10 | 0.68 |
| baseline neg affect | baseline life interference | 0.24 | 0.17 |
| PROMIS anxiety | baseline life interference | 0.28 | 0.10 |
| anxiety in exposure 1 | baseline life interference | 0.19 | 0.46 |
| anxiety in exposure 2 | baseline life interference | 0.32 | 0.17 |
| life interference after VRET | baseline life interference | 0.56 | 0.01 |
| severity after VRET (SPQ) | baseline life interference | 0.47 | 0.03 |
| severity after VRET (MFS) | baseline life interference | 0.44 | 0.05 |
| baseline severity (MFS) | baseline severity (SPQ) | 0.80 | <.001 |
| baseline pos affect | baseline severity (SPQ) | 0.04 | 0.90 |
| baseline neg affect | baseline severity (SPQ) | 0.18 | 0.31 |
| PROMIS anxiety | baseline severity (SPQ) | 0.26 | 0.12 |
| anxiety in exposure 1 | baseline severity (SPQ) | 0.23 | 0.35 |